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MreB is a structural membrane-associated protein which is one of the key components of the bacterial
cytoskeleton. Although it plays an important role in shape maintenance of rod-like bacteria, the
understanding of its mechanism of action is still not fully understood. This study shows how segmented
flow and microdroplet technology can be used as a new tool for biological in vitro investigation of this
protein. In this paper, we demonstrate cell-free expression in a single emulsion system to express red
fluorescence protein (RFP) and MreB linked RFP (MreB–RFP). We follow the aggregation and
localisation of the fusion protein MreB–RFP in this artificial cell-like environment. The expression of
MreB–RFP in single emulsion droplets leads to the formation of micrometer-scale protein patches
distributed at the water/oil interface.
1. Introduction
Over the last decade, numerous studies have demonstrated the
unique contribution that microdroplet technology offers in bio-
logical and chemical investigations.1–3 These methods have
generally been implented within segmented flow microfluidic
systems, resulting from the introduction of an aqueous phase
into a continuous oil phase, which can produce microdrops at
rates in excess of 1000 s1. The impact of the technology is related
to the small reaction volumes (ranging from 109 L to 1015 L)
with associated short diffusion distances. This, coupled with
advection within the droplets as they pass through microfluidic
systems, results in decreased times for reactions, when compared
to conventional techniques.4 The small volumes are also associ-
ated with high local concentrations of reactants, even when
absolute quantities are small, leading to reduced reagent costs.
Microfluidic technology enables scientists to manipulate
droplets in a controlled manner (providing tools that allow
merging, splitting, and sorting). Several detailed literature
reviews of microdroplet applications have been published
detailing how the technology has begun to impact in the
cosmetics, pharmaceutical and food industries.5–8
Methods involved with combining microdroplet technologies
with synthetic biology techniques have proved particularly
challenging and innovative.9–17 Customised DNA templates and
commercially available cell-free expression systems have been
combined and encapsulated in microdroplets for the synthesis of
enzyme and water soluble proteins, such as green fluorescent
protein (GFP) and red shifted GFP (rsGFP) .13–17
Developments in synthetic biology have potential applications
in the construction of artificial cells and more broadly in the
production of synthetically created biological structures in arti-
ficial environments, like single-emulsion droplets. These
constructs, commonly known as water-in-oil or W/O microdrops
provide a tool which enables study of biological components in
isolation, or can be used to transplant useful biological pathways
into an easily controlable experimental platform to achieve
a specific goal. For example, during the manufacture of drugs or
biofuels, reactions can be carried out in a droplet microreactor
possessing many of the physiochemical properties of in vivo cells
(it is of a similar size to a cell and has a hydrophobic/hydrophilic
interface with a similar curvature of a cell).
In this paper, we demonstrate the combination of microdropet
technology with cell-free protein expression for the production of
a structural membrane-associated protein (MreB) within an
artificial compartment. The single emulsion system offers an
ideal model to express the protein and to observe its behavior in
a cell-like system.
MreB is a bacterial actin homologue protein, which assembles
in bacterial cytoplasmatic filaments lying just underneath the
membrane. Its primary function is to organize the cell wall
synthesis machinery,18 but MreB also plays an important role in
the maintenance of shape in rod-like bacteria, e.g. E. coli.19,20
Recently it has been discovered that the origin of MreB’s
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membrane binding activity results from the presence of an N-
terminal amphipathic helix.18 Although scientists have proved
that MreB is responsible for bacterial elongation, the process by
which a bacterial cell becomes rod-shaped and a complete
understanding of its mechanism of action remain poorly
understood.21,22
To gain a better understanding of the role of MreB, scientists
have used many different methods of investigation to study its
structure, function and distribution, including site directed
mutagenesis, immunocytochemical fluorescence staining with
fluorescence microscopy, drug treatment and biophysical simu-
lation.18–22 In this paper, we now propose the use of microdroplet
technology as a possible new tool for biological in vitro investi-
gation of this protein. We show the cell-free production of this
structural protein, and study the dynamics of the expression
process, leading to the formation of micometer scale protein
patches distributed at the interface water/oil.
2. Experimental
2.1 Microfluidic droplet generator
The droplet-based microfluidic device was designed and fabri-
cated using standard soft lithographic techniques. Schematic
representation of the device is given in Fig. 1. The upper part of
device was made from PDMS (Sylgard 184, Dow Corning) cas-
ted on a silicon master structure. The silicon master itself was
fabricated using standard photolithographic processing
including pattern transfer and dry etching. Details of the device
fabrication can be found in our previous studies, involving
microdroplets including, for example.23
2.2 Plasmid construction
BioBrick ref BBa_I719015 was obtained from the Registry of
Standard Biological Parts, which contains gene expression
cassette of T7 promoter–RBS–mGFP–terminator in pSB1A2.
This plasmid was reconstructed as pB1A2_BX by introducing
BamHI and XhoI sites between the RBS and terminator instead
of mGFP gene.MreB gene was PCR-amplified from the genomic
DNA isolated from E. coli strain KO11 using the TIANamp
bacteria DNA kit (Tiangen, China). The reporter gene RFP was
amplified from BioBrick BBa_E1010, using RFP_forward and
RFP_reverse primers. The fusion protein gene MreB–RFP was
assembled by overlap extension PCR, with GS linker inserted
between the two genes. Then the MreB–RFP fragment was
inserted into pSB1A2_BX with BamHI and XhoI, resulting in the
vector pSB1A2_BX(MreB–RFP), which contains the target gene
expression cassette T7 promoter–RBS–MreB–RFP–terminator.
The fusion protein geneMreB–RFPwith GS linker and theRFP
gene alone were PCR-amplified from plasmid pSB1A2_BX(MreB–
RFP) using Platinum Taq DNA Polymerase High Fidelity
(Invitrogen, UK) and primers MreB_NT_for and MreB_NT_rev
or RFP_NT_for and MreB_NT_rev. The general protocol for the
polymerase was followed with an additional final 30 min extension
step at 68 C. After gel extraction (Qiagen, UK) the PCR products
were used in pEXP5-NT/TOPO Cloning reactions (Invitrogen,
UK) to obtain the plasmid pMreB-NT containing the N-terminal
His6 tagged fusion protein geneMreB–RFPwith GS linker and the
control plasmid pRFP-NT containing the RFP gene with an
N-terminal His6 tag.
2.3 MreB–RFP and RFP cell-free expression
E. coli extract and all solutions containing the biological
machinery for protein synthesis were purchased as a ribosomal
cell free extract from Invitrogen in the Expressway Cell-Free
E. coli Expression System. Following the manufacturer supplied
protocol, 1 mg of DNA plasmid was first mixed with E. coli
extract, T7 Enzyme mix, 75 mMmethionine, 50 mM amino acid,
RNase-free distilled water. The solution was then mixed with
a feeding solution containing 75 mM methionine, 50 mM amino
acid, RNase-free distilled water. This was loaded into a 100 ml
glass syringe (Hamilton) and connected to the device.
To observe the dynamics of MreB–RFP and RFP cell-free
protein expression, single emulsion devices comprising of 2 inlets
were used. One inlet was used for the continuous fluorinated oil
phase with 2% EA surfactant (Raindance Technologies), while
the other inlet was used for the ribosomal cell-free extract. Both
the oil–surfactant solution and cell-free reaction were introduced
into the devices via syringe pump (Harvard Apparatus) at initial
flow rates of 1 ml min1. The flow rate was subsequently reduced
to 0.5 ml min1 after the droplets were being constantly generated.
MreB–RFP and RFP protein expression in the droplets was
monitored using time lapse fluorescence microscopy (Axiovert
200 microscope, Carl Zeiss) at 32 C. Images were captured every
10 min in the first 6 h and every 30 min for 6 h afterwards. The
mean fluorescent intensities were quantified using ImageJ and
expressed as a function of time. The relative protein expression of
both MreB–RFP and RFP at each time point were normalised
against the initial background fluorescence intensities at droplet
formation, and were expressed in arbitrary units.
2.4 Confocal image
Ziess LSM 510 META microscope (Carl Zeiss Ltd., Welwyn
Garden City) was used to collect the fluorescence images, using
a Ziess LD-Plan Neofluor 40/0.6 Korr objective. The data
acquisition and signal processing were controlled by the supplied
Ziess software. Micrographs of MreB–RFP patches were
obtained using inbuilt digital zoom feature.
Fig. 1 Geometry of microfluidic device for W/O droplet generation. The
chip comprised two inlets for injection of two immiscible phases, a ser-
pertine chamber where droplets were stored and imaged and an outlet
useful for droplet collection outside the chip. The channel was created in
PDMS with height and width of 100 mm.
2940 | Analyst, 2012, 137, 2939–2943 This journal is ª The Royal Society of Chemistry 2012
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3. Results and discussion
3.1 MreB–RFP and RFP expression
Both the structural fusion protein (MreB–RFP) and the water
soluble protein (RFP), used as a control, were expressed in single
emulsion droplets. Increases in RFP fluorescence indicated
successful expression of fusion protein MreB–RFP by cell-free
expression. Droplets containing MreB–RFP showed the forma-
tion of MreB–RFP aggregates at the water/oil interface after 24
hours of incubation (Fig. 2A) while the RFP protein remained
homogeneously dispersed in solution (Fig. 2B). The dynamics of
Mreb–RFP and RFP expression are shown in Fig. 2C. The
fluorescence intensities of MreB–RFP and RFP at each time
point were normalised with their fluorescence intensities at the
starting point (10 different droplets were measured, n ¼ 10).
Fluorescence intensities showed a trend that increased over time.
The expression rate of RFP was higher than MreB–RFP,
showing approximately five-fold greater expression. The larger
DNA template for MreB–RFP with respect to RFP (1726 base
pairs compared to 675 base pairs) may account for the increased
expression rate of the smaller RFP template. Increased coding
length will result in slower transcription, and the slower diffusion
of the larger template within the microdroplet, leading to
increase time intervals between transcription events.
The mRNA levels correspond to protein expression. Differ-
ences in protein concentrations are 20–40% of those attributed
to mRNA levels.24,25 In addition to mRNA levels, ribosome
density (the number of ribosomes on active mRNAs normalised
by transcript length) may also play a role in the production of
proteins. The longer those transcripts are, the slower the
translation process will be. Moreover, the long transcripts
require a number of bound ribosomes to produce new proteins,
which also effects the synthesis rate.26 In addition to the size of
the encoding sequence, conformation change of RFP
might have an impact on the fluorescence intensity of the
MreB–RFP fusion protein. The fusion protein might cause
structural hindrance or misfolding to RFP that affect RFP
intensity.
3.2 MreB–RFP aggregates at the interface
Fig. 3A–C shows confocal Z-stack images of a single emulsion
droplet containing MreB–RFP aggregates (bottom, equatorial
and top view). The images revealed that cell-free production of
MreB–RFP in microdroplets led to the formation of 3 mm
diameter patch-like aggregates distributed at the water/
oil interface (Fig. 3D and E). The distribution of MreB at the
interface might be affected by its structure. MreB has an
N-terminal amphipathic helix that binds directly to cell
membrane. The binding is relatively strong due to the hydro-
phobicity of the amphipathic helix. A stable mutant of E. coli
MreB lacking the N-terminal amphipathic helix does not bind
strongly to membrane while the wild-type E. coli MreB does.18
One implication is that once the MreB–RFP adsorbs at the
water/oil interface, it might be difficult to dissociate from the
interface.
Fig. 2 Cell-free MreB–RFP and RFP expression in single emulsion. The
fluorescence images of droplets expressing MreB–RFP and RFP were
acquired 24 hours after starting the reaction (incubated at 32 C). MreB–
RFP forms aggregates localised at the water/oil interface (A) while the
RFP protein remained dispersed throughout the droplet (B). The relative
protein expression of both MreB–RFP and RFP showed a trend that
increased with time (C). The fluorescence intensities of MreB–RFP and
RFP at each time point were normalised with their fluorescent intensities
at the starting point (n ¼ 10).
Fig. 3 Confocal images of MreB–RFP protein patch formation in
microdroplets after 24 hours of incubation. (A) Bottom view of a single
emulsion droplet containingMreB–RFP aggregates; (B) equatorial cross-
section of the droplet, showing the localisation of theMreB–RFP patches
to the interfacial region; (C) top view of the single emulsion droplet
containing MreB–RFP aggegates. Scale bar ¼ 20 mm; (D) reconstructed
3Dmodel of a microdrop with aMreB–RFP aggregate, constructed from
confocal z-stack. Scale bar ¼ 20 mm; (E) close-up of MreB–RFP patch
showed the average size of patches within the droplets was approximately
3 mm (E). Scale bar ¼ 3 mm.
This journal is ª The Royal Society of Chemistry 2012 Analyst, 2012, 137, 2939–2943 | 2941
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3.3 Formation of MreB–RFP aggregates
The formation of MreB–RFP aggregates depended upon
droplet size and incubation time. Droplets with small size
(#50 mm in diameter) showed the formation of MreB–RFP
aggregates after 24 hours of incubation (Fig. 3), while the
MreB–RFP protein remains dispersed in solution within drop-
lets larger than 50 mm in diameter (Fig. 4A). For larger droplets,
it took about 96 hours to form aggregates similar to those seen
in smaller droplets (Fig. 4B). The surface area to volume ratio
might account for the heterogeneous kinetics of patch forma-
tion in different sizes of droplets; the larger surface area to
volume ratios for smaller droplets leading to shorter diffusion
times to the interface.
There are two possible hypotheses that could explain the
formation of aggregates. First, the MreB–RFP monomers
aggregate and form a polymer before moving to the interface
(Fig. 5A). Monomer binding to the interface could be prevented
prior to polymerization, if the amino acid residues comprising
the amphipathic membrane-binding helix are sequestered within
MreB’s 3D protein structure. The helix could be released by
morphological changes induced in the monomer during the
process of polymerization. Alternatively, the monomers
adhere to the interface prior to aggregation to form a larger
polymer (Fig. 5B). Adhesion of the monomers to the interface
might be another phenomenon to obscure the hydrophobic part
from the aqueous medium before forming the aggregation.
However, these two possible hypotheses require further
investigation.
Conclusions
We demonstrate the combination of microdroplet technology
with cell-free protein expression in order to examine the aggre-
gation and localisation of MreB, a prokaryotic membrane-
associated protein within a cell-like facsimile. The aggregation
kinetics depend on droplet size, with aggregates showing a pref-
erence for localisation at the water/oil interface, consistent with
expectations. Results obtained show the stability of the W/O
droplets, the homogeneity of distribution of RFP and aggrega-
tion of MreB at the W/O interface, indicating that single emul-
sion microdroplets are an interesting experimental platform for
the study of biological systems. Continuing experiments in this
area show the potential to elucidate the mechanism of this action
of this protein, revealing how it exercises control over bacterial
cell morphology.
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